Literature DB >> 808379

Treatment of essential hypertension with trimazosin, a new vasodilator agent.

N D Vlachakis, M Mendlowitz, D De Guzman de Guzman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 808379

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  4 in total

1.  Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.

Authors:  J Vincent; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

2.  Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.

Authors:  L Sampieri; C Cuspidi; L Boselli; L Angioni; G Castiglioni; A Zanchetti; G Mancia
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

Review 3.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

4.  Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension.

Authors:  C K van Kalken; J van der Meulen; P L Oe; R Vriesendorp; A J Donker
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.